AbSci
The global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry. Learn more
Launch date
Employees
Market cap
AUD684m
Enterprise valuation
AUD481m (Public information from Sep 2024)
Share price
$4.31 ABSI
Vancouver Washington (HQ)
Authorizing premium user...